Cited by 65Atrial Fibrillation Management and OutcomesInflammatory Biomarkers in Disease PrognosisHeart Failure Treatment and Management

Association of sST2 and hs-CRP levels with new-onset atrial fibrillation in coronary artery disease

Nortamo, Santeri, Ukkola, Olavi, Lepojärvi, Samuli, Kenttä, Tuomas, Kiviniemi, Antti, Junttila, Juhani, Huikuri, Heikki, Perkiömäki, Juha·2017·International Journal of Cardiology

Abstract

Background The data on biomarkers as predictors of atrial fibrillation (AF) in patients with coronary artery disease (CAD) are limited. Methods A total of 1946 patients with CAD were recruited to the ARTEMIS study. At baseline, the study patients underwent clinical and echocardiographic examinations and had laboratory tests. The patients (n=1710) with the information about the occurrence of new-onset AF during the follow-up were included in the present analysis. Results During 5.7±1.5years of follow-up, 143 (8.4%) patients developed a new-onset AF. Higher values of soluble ST2 (sST2) (20.2±10.8 vs. 17.5±7.2ng/mL, p=0.005), high-sensitivity troponin T (hs-TnT) (11.9±10.2 vs. 10.3±8.3ng/L, p=0.005), high-sensitivity C-reactive protein (hs-CRP) (3.3±5.9 vs. 2.0±4.4mg/L, p Conclusion A biomarker of fibrosis, sST2, and a biomarker of inflammation, hs-CRP, predict the risk of occurrence of new-onset AF in patients with CAD. These biomarkers contributed to the discrimination of the AF risk model, but did not improve it markedly.

Integrity signals

Registry

Crossref · 10.1016/j.ijcard.2017.07.022

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Elite athletes may present higher levels of profibrotic markers which have been associated with incident or recurrent AF in the general population, including galectin-3, ST2, miR-21, TIMP-1, CITP, and PICP.

    “Elite athletes may present higher levels of profibrotic markers which have been associated with incident or recurrent AF in the general population [66,67,68], including galectin-3 [69], the suppression of tumorigenicity 2 (ST2) [70], and microRNA-21 (miR-21) [71], as well as tissue inhibitors of metalloproteinase 1 (TIMP-1), C-terminal telopeptide of type I collagen (CITP), and procollagen type I”

The citation lists haven’t been fetched yet

References 43 · Cited by 65

Authors
Nortamo, S., Ukkola, O., Lepojärvi, S., Kenttä, T., Kiviniemi, A., Junttila, J., Huikuri, H., & Perkiömäki, J.
Affiliations
Oulu University Hospital (FI)
Corresponding author
Perkiömäki, Juha
Venue
International Journal of Cardiology
Publisher
Elsevier BV
Published
2017-12
Volume
248
Pages
173-178
ISSN
0167-5273 (ISSN-L)
OpenAlex
W2757442080
Cited by
65
References
43
Citations by year
2026: 1 · 2025: 8 · 2024: 10 · 2023: 5 · 2022: 6 · 2021: 10 · 2020: 13 · 2019: 5 · 2018: 5 · 2017: 1 · 2016: 1
FWCI
5.07
Type
journal article
Language
en
Open access
closed
Locations
  • International Journal of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Sigrid Juselius Foundation
  • Finnish Foundation for Cardiovascular Research
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
  • Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Keywords
coronary artery disease, soluble ST2, high-sensitivity C-reactive protein, high-sensitivity troponin T, brain natriuretic peptide, biomarkers, fibrosis, inflammation, risk prediction, left atrial diameter, cholesterol-lowering drugs, echocardiography, risk factors
MeSH terms
Interleukin-1 Receptor-Like 1 Protein, Aged, Atrial Fibrillation, C-Reactive Protein, Coronary Artery Disease, Female, Follow-Up Studies, Humans, Male, Middle Aged, Biomarkers

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review